Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : AMERICAN BIOMED, Minimally Invasive Technology (ABMI) -- Ignore unavailable to you. Want to Upgrade?

To: Malko who wrote (846)	5/10/1998 10:51:00 PM
From: Jeffrey L. Henken	Read Replies (2) \| Respond to of 2887

Further comments on statements made by Mr. Lepo to Greg over on the Yahoo thread: Greg in your post you stated that Mr Lepo at Coffin Communications stated the following: <>Also, he stated the allergic reaction to Latex was not as big of a deal as the chance a latex balloon breaking apart. HE said of any safety issue that would be the one that is the selling point.<> These are both big selling points. In my investor packet is a study which shows that latex catheters rupture more often than American BioMed's catheters. When a latex catheter ruptures it fragments and can create a very real health risk in the patient's blood stream. Still latex allergies are indeed very real and are becoming more prevalent and recognized every day. I think that there is some possibility that Mr Lepo is still among that portion of the population that underestimates the potential for a severe allergy to latex to cause anaphylatic shock and even, if not treated promptly, death. Regards, Jeff